CLINICAL_TRIALS
trial_result
· 2017-04-26
Clinical Trial Update: Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001) [Phase 2]
Summary
Phase 2 study evaluating the early bactericidal activity of bedaquiline (TMC207) in pulmonary tuberculosis; results were posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-26